Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kayukova (Moscow, Russian Federation), Z. Luluyeva (Moscow, Russian Federation), T. Bagdasaryan (??????, Russian Federation), A. Ergeshov (Moscow, Russian Federation). Side effects of tuberculosis chemotherapy: intestinal dysbiosis. 500

Member's Comments

No comment yet.

Related content which might interest you: The gut microbiota state in patients with pulmonary tuberculosis. Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 The study of nonspecific microflora in lung tuberculosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 503s Year: 2006 The attenuation of cytokine response might be correlated with gut dysbiosis in nontuberculous mycobacteria lung disease Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Surgical treatment of intestinal tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 646s Year: 2005 The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 656s Year: 2005 Effect of cisplatin on bacterial translocation in an experimental model whit increased intestinal microflora Source: Eur Respir J 2003; 22: Suppl. 45, 433s Year: 2003 Side effects of tuberculosis chemotherapy in women of reproductive age: vaginal dysbacteriosis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 The difference of airway microbiota between nontuberculous mycobacteria lung disease and bronchiectasis Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Macrolides, inflammation and the lung microbiome: cause or effect? Source: International Congress 2018 – State of the art session: Airways disease Year: 2018 An influence of small doses of corticosteroids on immune defense in active pulmonary tuberculosis in humans Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function Source: Eur Respir J, 55 (3) 1901692; 10.1183/13993003.01692-2019 Year: 2020 H.p. is good for you: protective effects of helicobacter infections in airway disease Source: Annual Congress 2013 –Significance of intestinal and respiratory tract cross-talk in chronic lung diseases Year: 2013 How does the gut microbiota regulate immune responses in the airways? Source: Annual Congress 2006 - Can environmental exposures prevent allergic disease, what are the mechanisms and how important is timing of exposure? Year: 2006 Intestinal parasiroses in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010 Effectiveness of partial lung resection at multi-drug resistance of tuberculosis mycobacteria Source: Annual Congress 2012 - Surgery for infections and congenital diseases Year: 2012 The pulmonary bacterial and fungal microbiota in sarcoidosis patients. Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009 Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 How infections can modify lung immunity Source: Guideline 2001 Year: 2001 How infections can modify lung immunity Source: Eur Respir J 2001; 18: 442-443 Year: 2001